We hypothesized that the alveolar structures may contain extracellular macromolecules with antioxidant properties to defend against oxidants. To evaluate this 51Cr-labeled human lung fibroblasts (HFL-1) and cat lung epithelial cells (AKD) were exposed to a H202-generating system and alveolar epithelial lining fluid (ELF) from healthy nonsmokers was tested for its ability to protect the lung cells from H202-mediated injury. The Invest. 1990. 86:962-971.)
Introduction
The alveoli of the lower respiratory tract provide the functional interface between the atmosphere and the body, allowing the exchange of oxygen and carbon dioxide between air and blood (1) . As a consequence of this role, the cells composing the alveolar walls are placed under a burden of toxic oxygen radicals that is commonly greater than that of any other tissue (2, 3) . In addition to the oxidants generated within the cells themselves (4) , lung parenchymal cells are necessarily exposed to oxidant pollutants of the air, including oxides of nitrogen, ozone, and the gaseous phase of cigarette smoke (5, 6) . Furthermore, the lower respiratory tract contains alveolar macrophages, cells that phagocytose inhaled particulates such as inorganic dusts, infectious organisms and particulates in cigarette smoke, but in doing so release toxic oxidants into their environment (7) . Finally, many acute and chronic lung disorders are associated with inflammatory processes in the lower respiratory tract characterized by marked accumulation of activated inflammatory cells releasing oxidants (8-1 1) .
Like cells in other organs, the parenchymal cells of the lower respiratory tract are able to suppress the intracellular burden of oxidants with an array of intracellular antioxidants that include the superoxide dismutases (12), catalase (13) , and the glutathione system (14) . However, because of the unique situation of the alveolar structures with their potential exposures to a large oxidant burden in the extracellular milieu, we have considered the possibility that there may also be antioxidant defense mechanisms that would serve as a first line of defense against oxidants outside of the parenchymal cells.
To evaluate this concept, we tested the epithelial lining fluid (ELF)' of the human lower respiratory tract for its ability to provide antioxidant protection to lung parenchymal cells from oxidants formed outside of the cells. To accomplish this, we have used a model system in which epithelial lining fluid was evaluated in vitro for the presence of macromolecules that might protect human lung fibroblasts or cat lung epithelial cells from a burden of hydrogen peroxide, an oxidant that plays a central role in the generation of a variety of oxidants to which lung parenchymal cells are potentially exposed.
were then washed three times with PBS (M.A. Bioproducts, Walkersville, MD). The cytotoxicity assay was performed by incubating the "Cr-labeled lung cells in "assay media" that included 0.5 ml of Earle's balanced salt solution (EBSS;' Biofluids Inc., Rockville, MD) supplemented with 55 mM glucose. To this was added 0.1 ml ofeither PBS or epithelial lining fluid (see below). Oxidant production was initiated by adding 50 gl of a glucose oxidase solution at varying concentrations (Boehringer-Mannheim Biochemicals, Indianapolis, IN) and the cells were incubated in 5% CO2 at 370C for 8 h. Protease contamination of glucose oxidase was minimal (65 U glucose oxidase increased the optical density of 1 ml 0.5% azocasein at 520 mm by 0.01 absorbance units after 1 h at 370C) as measured by the proteolytic assay described by Monboisse et al. (24) . To ensure that "Cr release from target cells was induced by oxidants, the cells were also incubated in the presence of glucose plus glucose-oxidase and either 1 mM growth-stimulating hormone, 4 mM cysteine, 80 mM dimethylthiourea, 100 U/ml catalase, boiled catalase (boiled at 100IC for 15 min) or 1 mg/ml SOD (all reagents from Sigma Chemical Co. [St. Louis, MO] ). Maximum releasable "Cr was assessed by incubating cells with 2% Triton-X 100 (Research Products International Inc., Elk Grove Village, IL) and background release was evaluated by incubating cells in the absence of glucose oxidase. At the end ofthe incubation period, "Cr release in the supernatant was quantitated. Cell injury was defined in terms of a cytotoxicity index (CI): [(A-B)/(C-B)] X 100, where A = disintegrations per minute released into the media of the test sample, B = disintegrations per minute released from control cells (i.e., background release) and C = disintegrations per minute released from cells treated with 2% Triton-X 100. To insure that the "Cr measured in the supernatants reflected "Cr release from cell injury and not cell detachment, supernatants were centrifuged at 500 g for 10 min and "5Cr was quantitated.
The amount of chromium detected in centrifuged supernatants was identical to that of noncentrifuged supernatants even in the presence of sufficient glucose oxidase to induce maximal cytotoxicity. Furthermore, the cytotoxicity indices obtained by measuring "Cr release correlated with those calculated from lactate dehydrogenase measurements in the supernatants (r = 0.983, P < 0.001). All subsequent cytotoxicity indices were therefore calculated from "'Cr quantitation of non-centrifuged supernatants. Using this index, maximum cell injury was 100% and an index of0% indicated no release of chromium above the spontaneous "leak" during the culture period. Typical counts for B were -1.7 X 104 dpm/ml for AKD cells and 2.0 X 104 for HFL-I cells, whereas typical counts for C were 10' dpm/ml for both cell types.
The oxidants generated in 1 h at 37°C by the glucose-glucose oxidase system were evaluated by incubating the assay media with increasing amounts of glucose oxidase (0-10 mU/ml). The amount of hydrogen peroxide was quantitated with 0.28 mM phenol red and 8.5 U/ml of horseradish peroxidase (type II; 200 purpurogallin units/mg; Sigma Chemical Co.) (25) . After 1 h, the reaction mixture was treated with 0.01 N NaOH and assessed spectrophotometrically at 610 nm. Superoxide production was assessed by adding 80 ,uM ferricytochrome-c (type III; Sigma Chemical Co.) and evaluating the mixture at 550 nm (25) .
Evaluation ofthe antioxidant properties of unfractionated ELF (ELF) was obtained by bronchoalveolar lavage of 16 healthy nonsmoking individuals using 5 20-ml aliquots of sterile 0.9% NaCl in each ofthree sites as previously described (26) . All of these individuals were determined to be free of lung disease by history, physical examination, chest x-ray, and lung function tests. The fluid was separated from the lung cells by centrifugation at 500 g for 5 min. Because the ELF, as recovered by bronchoalveolar lavage, is diluted -100-fold by the saline, it was necessary to concentrate the fluid before it was assessed for its antioxidant properties. To accomplish this, the fluid was concentrated 50-fold by pressure filtration on a YM-10 membrane (Amicon Co., Lexington, MA). Thus, the antioxidants assessed were only those retained by the filter, i.e., Mr -> 10 kD. Increasing amounts of the concentrated ELF were added to the cytotoxicity assay (before the addition of the glucose-oxidase), and the % cytotoxicity determined at 8 h, 370C.
The actual amount of ELF added to each assay was determined by combining the measurement of the volume of ELF recovered by lavage and the ratio ofthe albumin in the concentrated fluid to the albumin in the unconcentrated fluid. The amount of ELF recovered by lavage was determined by the urea method (27) . To relate all antioxidant activities to that in vivo, the amount of albumin was quantified by radial immunodiffusion in concentrated fluid and enzyme-linked immunosorbent assay in the unconcentrated lavage fluid. The ratio of antioxidant activity to albumin in the concentrated fluid was then used to determine the antioxidant activity in a volume of ELF containing an equivalent amount of albumin. In this context, wherever amounts of ELF are stated in the text, this amount refers to the calculated amount of ELF added, i.e., the estimate of the actual volume of ELF present in the lower respiratory tract.
Fractionation ofantioxidant macromolecules in ELF
The concentrated ELF was fractionated by two methods: (a) separation into water-and lipid-soluble components by density gradient (NaBr) centrifugation; and (b) fractionation by molecular weight.
The water and lipid components of ELF were separated by layering 12 ml of unconcentrated bronchoalveolar lavage fluid containing 1.56 M NaBr (Sigma Chemical Co.) under 20 ml of 0.15 M NaCl, 1.27 M NaBr, which was layered under 8 ml of0.15 M NaCl and centrifuged at 100,000 g, at 40C for 3 h (SW-27 rotor; Beckman Instruments, Inc., Fullerton, CA) (28) . The lipid fraction was collected from the upper interface (density = 1.085) and the water-soluble fraction was collected from the 12 ml at the bottom of the gradient. The lipid fraction was washed three times in PBS and brought to a volume of 240 Ml in PBS.
The soluble fraction was concentrated by pressure filtration on a YM-I0 membrane to a volume of 240 Ml in PBS. Since sample preparation required a prolonged period of time during which ELF was exposed to air, it was necessary to add a reducing agent to each fraction to prevent sample oxidation. Each fraction was therefore subsequently treated with 20 mM 2-mercaptoethanol and dialyzed extensively against PBS for 12 h. Control samples ofbuffer and 2-mercaptoethanol heated in the same way did not affect the cytotoxicity assays. After this, 80 ul of each fraction were tested in the cytotoxicity assay.
To fractionate the ELF by molecular weight, concentrated ELF was centrifuged at 12,000 g for 15 min and fractionated by HPLC (Beckman Instruments, Inc.) using a Superose 6 and Superose 12 column in series (Pharmacia Fine Chemicals, Piscataway, NJ) in 0.15 M NaCl, 7.5 mM sodium phosphate, pH 7.4. Fractions corresponding to various molecular weights were pooled, concentrated by ultrafiltration to the same volume as the original sample on Minicon-CS 15 membranes (Amicon Co.) and tested for their antioxidant properties in the cytotoxicity assay as described above.
Evaluation ofserum proteins in ELF that might serve as antioxidants Four serum proteins, albumin, IgG, ceruloplasmin, and a l-antitrypsin, all known to be present in ELF (29) , were each evaluated for their antioxidant properties in the cytotoxicity assay. ELF and serum concentrations of each of these proteins were determined by radial immunodiffusion assay (Calbiochem-Behring Corp., La Jolla, CA). The concentrations present in ELF were used to determine the range of values to be assessed in the cytotoxicity assay and the concentration required to provide a 50% reduction in the cytotoxicity index was determined.
Identification ofcatalase as the major antioxidant macromolecule in ELF Together, preliminary fractionation data and the measurement of the relative contribution to ELF antioxidants by serum proteins suggested that: (a) the majority of the antioxidant protection offered by ELF Evaluation ofthe possible sources ofELF catalase
Since catalase is predominantly an intracellular enzyme, it is likely that ELF catalase is derived from one of the multiple cell types present in the lower respiratory tract. Thus, the possible sources of ELF catalase include red blood cells, lung inflammatory cells, and lung parenchymal cells. To gain insight as to whether these cells contribute to the catalase present in ELF, the following experiments were performed. Red blood cells. Although red blood cells are rarely found in bronchoalveolar lavage samples of normal individuals, to determine whether red blood cell lysis contributed to the presence of catalase in ELF, either as an in vivo process or as an artifact of the lavage procedure, concentration ofhemoglobin in ELF was quantified by recording the absorbance of the Soret band at a wavelength of 414 nm (32). The ratio of catalase activity to hemoglobin content of ELF was compared with that of the red blood cell lysate supernatant.
Lung inflammatory cells. To exclude the possibility that the lavage procedure artifactually contributed to the ELF catalase by lysing lung inflammatory cells during the procedure itself, bronchoalveolar lavage fluid obtained from a healthy individual was separated in two aliquots.
One aliquot was immediately centrifuged (500 g, 5 min) and-the catalase content was determined in the supernatant. The second aliquot was aspirated through the bronchoscope in the laboratory using the same suction apparatus as in the in vivo procedure, the recovered fluid was immediately centrifuged (500 g, 5 min), and the catalase content of the ELF was determined.
Ifthe catalase found in ELF was derived from cell types other than (or in addition to) inflammatory cells, the relative amounts of various cytoplasmic enzymes found in ELF should differ from that of the inflammatory cell populations present in the lower respiratory tract. To evaluate this, the amounts of the antioxidant enzymes catalase, SOD, glutathione peroxidase, and glutathione reductase were measured in ELF and in lung inflammatory cells and their relative proportions compared with that in ELF. ELF was prepared as described above, centrifuged at 12,000 g for 5 min, and assays for enzyme activity were performed on the supernatant. Inflammatory cells recovered by lavage were washed three times with PBS and suspended in PBS (106/ml), sonicated (Sonifier, Ultrasonics Inc., Plainview, NY), centrifuged at 25,000 g for 15 min, and antioxidant enzyme activity measured in the supernatants. For 
Results
Oxidant-generating system and its effect on human lung parenchymal cells. The reaction of glucose with the enzyme glucose-oxidase resulted in the generation of hydrogen peroxide in the media but no detectable superoxide anion (Fig. 1) . The amount of H202 generated by this reaction was dependent on the concentration of glucose-oxidase, and the release of H202 occurred over a gradual period of time, thus simulating the release of H202 from activated phagocytes. When the hydrogen peroxide generating system was incubated with labeled human lung fibroblasts or cat lung epithelial cells, a significant amount of 5"Cr was released into the media. Glucose oxidase in the absence of glucose did not induce the release of 5"Cr from HFL-I and AKD cells up to concentrations of60 mU/ml (Fig. 1) . Furthermore, the release of51Cr from HFL-1 cells was suppressed by 100 U/ml catalase (CI: from 78±2 to 0+2%, P < 0.001), 1 mM GSH (CI: from 18±3 to 0+1%, P < 0.01) 4 mM cysteine (CI: from 24±1 to 0±1%, P < 0.01) but unchanged by 1 mg/ml SOD (CI: from 78±2 to 79±2%, P > 0.5). (8 h, 370C) , and the amount of hydrogen peroxide (H202) and superoxide anion (°2) generated were quantified using phenol red and ferricytochrome-c, respectively, as indicators. Only H202 is produced by this system. (B) Cytotoxicity of human lung fibroblasts (HLF-1) and (C) cat lung epithelial cells (AKD) caused by the glucose-glucose oxidase oxidant-generating system. 51Cr-labeled HFL-I and AKD cells were incubated with (C) and without (o) glucose (55 mM) and increasing amounts of glucose oxidase for 8 h, 370C and a cytotoxicity index determined. The relative amount of 5"Cr released paralleled that of the amount of H202 generated at each concentration of glucose oxidase.
5"Cr released from AKD cells was suppressed by 100 U/ml catalase (CI: from 20±2 to 1±1%, P < 0.05), 1 mM GSH (CI: from 13±2 to 0±1%, P < 0.01) but unchanged by heat-inactivated catalase (CI: from 20±2 to 21+3%, P > 0.5) and by 1 mg/ml SOD (CI: from 20±2 to 21±2%, P > 0.5). Glucose-oxidase at a concentration of 8 mU/ml induced maximum release of 'Cr from the HFL-1 cells; this concentration ofglucose-oxidase generated 90 nmol H202/h per ml of media. Because the in vitro system was designed to evaluate the macromolecules in ELF that might provide antioxidant protection against a typical burden of H202 in the human lower respiratory tract, the amount of glucose oxidase used in all subsequent experiments was based on the estimated amount of H202 generated by inflammatory cells in the ELF of cigarette smokers (a typical example of a common human situation in which the lower respiratory tract must content with increased oxidant burden). Since 106 alveolar macrophages from cigarette smokers release from 3 to 8 nmol of H202/h in vitro (9) Effect of normal epithelial liningfluid on the oxidant-mediated injury to human lung parenchymal cells. ELF from healthy nonsmoking individuals markedly reduced the H202 induced cytotoxicity of the target cells in a dose-dependent manner, with 20 ,ul of ELF reducing the HFL-l cytotoxicity index from 65±4 to 0±1% (Fig. 2 , P < 0.001 compared with no ELF) and the AKD cell cytotoxicity index from 39±2 to 8±4% (Fig. 2 B , n = 8, P < 0.01). By itself, the ELF did not alter the spontaneous release of5Cr from the lung parenchymal cells in the absence of oxidants (data not shown).
Fractionation ofantioxidant macromolecules in ELF. Centrifugation of ELF on a sodium bromide density gradient-separated it into a lipid-free, water-soluble fraction and a lipidenriched fraction. Whereas the lipid-enriched fraction caused only a slight reduction in the cytotoxicity index to 45±5% (Fig.  3 , n = 6, P < 0.05 compared with oxidants alone), the watersoluble fraction of ELF markedly reduced the cytotoxicity index to 0±1% (n = 6, P < 0.001 compared with oxidants alone; P < 0.005 compared to the lipid soluble fraction), suggesting that most of the anti-H202 activity of ELF was in the water-soluble fraction.
To further characterize the molecules in the water-soluble fraction that may contribute to the antioxidant properties of ELF, the ELF was fractionated by gel filtration, and fractions corresponding to various molecular weight ranges were tested in the cytotoxicity assay. All of the antioxidant activity eluted Fig. 1 . The water-soluble and lipid components of ELF were separated on a sodium bromide gradient, both fractions were dialyzed against PBS, and each fraction was then tested for its ability to protect HFL-1 cells against the H202 generated in the cytotoxicity assay. The amount of ELF placed on the sodium bromide gradient was 240 zd, and each of the water-soluble and lipid-enriched fractions was adjusted to a final volume of 240 yd. The amounts of whole ELF and water-soluble and lipid components used in the cytotoxicity assay were each 80 Al per 500 ul of test media.
in a single fraction corresponding to a molecular mass range of 100-30 kD (Fig. 4) . Furthermore, catalase activity was clearly detectable in this fraction but not in other fractions (Fig. 4 A) .
Antioxidant properties of serum-derived proteins in ELF.
Since many of the water-soluble components of ELF are proteins derived from serum, the serum proteins likely to give anti-H202 protection, ceruloplasmin, and a -antitrypsin, were examined as were two major serum proteins, albumin, and IgG not likely to provide anti-H202 protection (Table I) . Although human albumin (2 mg/ml) and immunoglobulin (2 mg/ml) did not suppress the oxidant-mediated cytotoxicity in the in vitro test system, ceruloplasmin at a concentration of 215±40 ,ug/ml and al-antitrypsin at a concentration of 450±100 gg/ml caused a 50% reduction in the cytotoxicity index (n = 6, P < 0.01, both compared to oxidants alone). However, although the addition of 40 jsl ELF to 1 ml media completed protected the lung cells against oxidant injury, the concentration ofceruloplasmin (0.8 8,g/ml) and a l-antitrypsin (8 ug/ml) in ELF were well below the levels necessary to provide significant antioxidant protection, suggesting that these serum proteins did not contribute to the anti-H202 protection observed in ELF.
Identification of catalase as the major ELF antioxidant macromolecule. Catalase activity (i.e., the ability to convert H202 to H20 plus 02) was clearly present in all samples of normal ELF (Fig. 5) . Furthermore, specific immunoabsorption of catalase from the ELF resulted in a complete loss of catalase activity from ELF. The antibody used to deplete ELF of catalase was specific to catalase and did not react with other red blood cell or serum proteins (Fig. 5) . Importantly, when catalase was immunoabsorbed from the ELF, the ELF no longer provided antioxidant protection to the lung parenchymal cells (P < 0.001). Whereas oxidants alone induced a cytotoxicity index of 64±3%, the pooled fraction eluting within the molecular weight range of 100,000 to 300,000 significantly reduced the cytotoxicity index.
antihuman ceruloplasmin antibodies or protein A (Pharmacia Fine Chemicals) did not result in a loss of ELF antioxidant properties, indicating that the loss of ELF antioxidant activity with the anticatalase chromatography was not due to a nonspecific interaction of ELF antioxidants with the affinity column. Consistent with the concept that catalase is the major ELF antioxidant macromolecule, was the observation that the minimum concentration of catalase (Sigma Chemical Co.) necessary to completely protect HFL-1 cells against 8 mU/ml glucose oxidase was 60 mU/ml (data not shown), while the minimum amount of ELF necessary to protect HFL-1 cells was 20 ,ul/ml (Fig. 2 A) , which corresponds to a catalase concentration of 76±12 mU/ml. Evaluation ofthe source ofELF catalase. Since catalase is predominantly an intracellular protein, the possible sources of ELF catalase include red blood cells, alveolar inflammatory cells, and lung parenchymal cells. Red blood cell origin of ELF catalase could be excluded since, although the ELF catalase concentration was 3.8±0.6 U/ml, the activity concentration in red blood cells was 10±2 mU/,gg hemoglobin (Hb) and all ELF samples used in this study contained < 1 ug/ml Hb. * Increasing amounts of each protein were added to the cytotoxicity assay using a H202-generating system and " Cr-labeled HFL-I cells as described in the legend to Fig. 1 . Shown is the concentration of each protein necessary to give a 50% reduction in the cytotoxicity index.
To insure that ELF catalase was not artifactually derived from lung inflammatory cell lysis during bronchoscopy, ELF catalase activity was measured before and after aspiration of bronchoalveolar lavage cells and fluid through the bronchoscope. No significant increase in ELF catalase activity was observed resulting from aspiration through the bronchoscope (ELF catalase before, 3.2±0.7 U/ml; after, 4.4±0.9 U/ml, P
>0.3).
Evidence suggesting that ELF catalase activity may be derived from lung cells (parenchymal as well as lung inflamma- tory cells) was provided by two observations. First, the ratios of intracellular antioxidant enzyme activity in ELF to that in lung inflammatory cells were markedly different from enzyme to enzyme (Table II) , suggesting that either lung inflammatory cells secrete certain antioxidant enzymes in a selective manner or cells other than lung inflammatory cells are also contributing to the antioxidant activity of ELF. Second, while studies of isozyme pattern of ELF catalase and lung inflammatory cell catalase from the same individual revealed similar patterns in 70% of those studied (for an example, see Fig. 6 , Subject A) distinctly different patterns were observed in 30% of those studied (see Fig. 6 , Subject B), strongly suggesting that, at least in these individuals, parenchymal cells as well as inflammatory cells contributed to the presence of catalase in the ELF.
Discussion
Parenchymal cells ofthe lower respiratory tract are potentially exposed to toxic oxidants in the extracellular milieu. The present study was designed to evaluate the hypothesis that there are macromolecules present in the ELF capable of providing an antioxidant screen against H202, an oxidant that directly, or through its metabolites, plays a central role in mediating parenchymal cell injury in the lung. The data demonstrate that the ELF of the normal human lower respiratory tract does contain such macromolecules and characterization of the anti-H202 properties of ELF revealed that most was attributable to the presence of catalase. Although the specific cellular origin of ELF catalase is not known, it is clear that this enzyme is capable of providing protection to lung parenchymal cells against extracellularly generated H202. Possible sources ofcatalase in ELF. Catalase (H202:H202 oxidoreductase; ECl . l .1.6), a 240,000-D enzyme present in virtually all mammalian cells (13, 37) , uses H202 as a substrate in the catalytic conversion of H202 to H20 plus 02 and peroxidatic reactions. All catalases are thought to be oligomers composed of four, 60,000-D polypeptide chains held together mainly through hydrophobic interactions (37) . Each chain is associated with a prosthetic group, protoporphyrin IX, located at the active site.
Catalase is synthesized by many cell types (38) (39) (40) (41) (42) (43) (44) . In the lung, histochemical studies of the parenchyma from a variety of mammalian species have demonstrated that most of the catalase located in the lower respiratory tract is located within alveolar macrophages (44) , type II alveolar epithelial cells, and Clara cells (39, [41] [42] [43] . In these cells, catalase is found predominantly in peroxisomes, cytoplasmic organelles containing an array of H202-generating enzymes and catalase (38) , but it also can be found in the cytoplasm (39), microperoxisomes (40) , and phagolysosomes (45) .
In alveolar macrophages, the enzyme is located predominantly within peroxisomes (44) sosomes (45) . When macrophages are activated by a phagocytic stimulus, catalase is transferred from peroxisomes to phagolysosomes, thus increasing the phagolysosome catalase content 20-fold (45) . Since lysosomal hydrolases are present in normal extracellular fluid of the lower respiratory tract (46) , and since activated macrophages can markedly increase their release of lysosomal enzymes (47) , it is possible that through this mechanism, alveolar macrophages contribute, at least in part, to the presence of catalase in normal ELF. Importantly, several lines of evidence suggest that the presence of catalase in ELF is not an "artifact" of analysis originating from lysis of inflammatory lung cells such as alveolar macrophages during bronchoalveolar lavage or subsequent processing of the cells. First, Hook (46) has shown that alveolar macrophages obtained by lavage and maintained in suspension for several hours do not release lactate dehydrogenase or glutamic oxalacetic acid, indicating that the lavage procedure does not induce any irreversible injury to the recovered cells. The same study also demonstrated that centrifugation of alveolar macrophages up to 27,000 g for as long as 30 min did not result in the release of these cytoplasmic enzymes into the supernatant (46) . Second, the present study indicated that repeated aspiration of lung inflammatory cells through the bronchoscope under conditions identical to those of the bronchoscopy, did not increase the catalase content of the supernatant. Third, whereas isoenzyme patterns of the catalase obtained from ELF and from lung inflammatory cells were identical in some individuals, the patterns were clearly different in others, suggesting that ELF catalase can originate from lung cells other than alveolar macrophages. However, these data are also consistent with the possibility that partial proteolytic degradation of ELF catalase may have contributed to the observed electrophoretic patterns.
While the different ratios of antioxidant enzymes in ELF to that in lung inflammatory cells argue against alveolar macrophage lysis as the source of ELF catalase, these data do not exclude the possibility that lung inflammatory cells may selectively secrete certain antioxidant enzymes. In this context, and since the variations in electrophoretic patterns of ELF catalase could conceivably represent partial proteolytic degradation, lung inflammatory cells, including alveolar macrophages, remain a potential source of ELF catalase activity.
Several lines of reasoning also argue against the possibility that the catalase found in ELF resulted from the trauma of the lavage procedure to type II or Clara cells. First, epithelial cells compose < 1% of the total cell population recovered by bronchoalveolar lavage (26) . Second, the ratio of proteins in bronchoalveolar lavage to those in serum decreases as their molecular weights increase, indicating that the alveolar capillary barrier is intact (29) . Third, morphometric studies by EM of lung parenchyma after whole lung lavage in dogs using much larger volumes of saline (500 ml) than used in the present study, demonstrated that cell membranes remained intact without any evidence of cell lysis or destruction (48) . Furthermore, the same study demonstrated that the number of intracellular lamellar bodies in type II cells remained unchanged, suggesting that intracellular molecules are not extruded from the epithelial lining cells by the lavage procedure. Finally, ELF catalase has been shown to be increased in the lower respiratory tract of smokers and patients with a variety of lung inflammatory disorders (49) . Since the bronchoalveolar lavage procedure was identical for each group, the differences in ELF catalase con- Figure 7 . Isoenzyme patterns of catalase from inflammatory cells and ELF obtained by bronchoalveolar lavage of normal individuals. Each sample, prepared in 150 mM NaCl, was adjusted to have 1 U/ml catalase activity and was electrophoresed (4 h) into a 5% polyacrylamide slab gel (without SDS). The gel was subsequently washed in water, immersed in 1 mM H202 for 10 min, rinsed in water, and stained with a solution of 30 mM potassium ferricyanide and 37 mM ferric chloride. Areas of the gel with e H202-stained dark green while areas of catalase activity (i.e., absence of H202) remained clear. Catalase patterns from two subjects (A and B) are shown, including that for inflammatory cells alone, ELF alone, or inflammatory cells and ELF together.
tioxidant properties are also present, including SOD, glutathione reductase, and peroxidase, and ceruloplasmin. The design of our study was such that we focused on anti-H202 defenses.
However, that SOD is present may be relevant since, by virtue of the fact that it converts O-to H202, its role may be in preventing the ability of O-radical to reduce Fe3" to Fe2 , (in conjunction with H202), which causes the formation of the toxic hydroxyl radical (55) or generation of a superoxide dependent neutrophil chemotactic factor (56) . Enzymes involved in the glutathione system, including the enzymes glutathione peroxidase and reductase, are also present in normal ELF. This is of interest in view of the high concentrations of GSH in ELF (57) , suggesting that this glutathione system may play a role in the protection of the lower respiratory tract against toxic peroxides present in the extracellular milieu. However, the problems in concentrating glutathione, a low molecular weight species that is rapidly oxidized when removed from tissues (58) Because of the large dilution of ELF caused by the use of saline to perform the bronchoalveolar lavage, ELF molecules were concentrated by pressure filtration, and thus only molecules with a molecular mass > 10 kD were analyzed. However, smaller antioxidant molecules such as vitamins A, C, and E are also present in biological fluids (62) (63) (64) (65) . Vitamin A acts predominantly as a quencher of singlet oxygen (62) , and vitamin E is thought to function mainly by interacting with lipid peroxy free radicals (RO2) and stopping the cyclic chain reaction of lipid peroxidation (63, 65) . Vitamin C has recently been reported in high concentration in the extracellular fluid of the lower respiratory tract (64) with most of it in the reduced state. Furthermore, as mentioned above, reduced glutathione is present in high concentrations in ELF, adding further to the antioxidant defenses.
In the context ofthe above, it is reasonable to conclude that the ELF of the normal lower respiratory tract contains a wide array of antioxidant molecules. Among these, catalase seems to play a unique role by providing a mechanism whereby high concentrations of H202 can be metabolized thus preventing oxidant-mediated parenchymal cell injury. Since H202 plays a central role in mediating lung parenchymal cell injury, it is likely that the presence of catalase in ELF provides an important antioxidant screen to the lower respiratory tract.
